Klinikum der Ludwig-Maximilians-Universitaet Muenchen

Site:	Klinikum der Ludwig-Maximilians-Universitaet Muenchen
Address:
City:	Munchen
State:	Bayern
Zip:	80336
Country:	Germany

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)	Recruiting	Active	Belzutifan	NCT04924075